These results suggested that the inhibitory effects of reynoutrin on inflammation, oxidative stress, cardiomyocyte apoptosis, and myocardial fibrosis may be related to its ability to up-regulate the S100A1 protein. The gene discussed is S100A1; the disease is Myocardial fibrosis.